A 2024 survey of eCOA professionals at sponsor organizations revealed that 50% of respondents identified eCOA Data Change ...

MALVERN, Pa., Feb. 05, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical ...

Visits to the doctor could be improved with the use of AI to record a patient's medical history provided concerns about ...

CereVasc has reported positive initial results in a pilot study of its eShunt System implant in treating elderly patients with normal pressure hydrocephalus (NPH). At the 90-day primary endpoint of ...

Accurate pain reporting in sickle cell disease is critical to effective pain assessment and management, but accuracy depends on patient comprehension of forms.

Immunotherapeutics have transformed cancer outcomes. It is crucial that response patterns seen with them are assessed ...

SALT LAKE CITY, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor ...

How a study evaluated nurses' knowledge and confidence in delivering systemic anti-cancer therapy patient education.

University of Calgary's Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic and genomic tumor testing and precision medicine, and INTERLINK Care Management, Inc. announced ...

MSD began worldwide recruitment for the trial and subjects are currently being enrolled. In the randomised trial, the ...